Samplix

Timeline

1. 28 Oct 2026Funding: Other$27.1MEU-Startups

   Danish BioTech Samplix secures €25 million in first close of financing round to scale antibody discovery (opens in a new tab)

   Danish biotechnology firm Samplix raised 25 million euros in the first close of a financing round led by WLanholding GmbH to scale its antibody discovery technology.